JPH0421637A - High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production - Google Patents
High polymer fine grain whose surface is modified with chitin derivative or chitosan and its productionInfo
- Publication number
- JPH0421637A JPH0421637A JP2122459A JP12245990A JPH0421637A JP H0421637 A JPH0421637 A JP H0421637A JP 2122459 A JP2122459 A JP 2122459A JP 12245990 A JP12245990 A JP 12245990A JP H0421637 A JPH0421637 A JP H0421637A
- Authority
- JP
- Japan
- Prior art keywords
- chitin
- chitosan
- latex
- high polymer
- polymer fine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002101 Chitin Polymers 0.000 title claims abstract description 50
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 28
- 229920000642 polymer Polymers 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000004816 latex Substances 0.000 claims abstract description 39
- 229920000126 latex Polymers 0.000 claims abstract description 39
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 15
- -1 carbodiimide compound Chemical class 0.000 claims abstract description 12
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims abstract description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 3
- 239000010419 fine particle Substances 0.000 claims description 15
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 239000013543 active substance Substances 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 239000002158 endotoxin Substances 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 8
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 7
- 239000000463 material Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229920001222 biopolymer Polymers 0.000 description 4
- 239000011859 microparticle Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 229940039227 diagnostic agent Drugs 0.000 description 2
- 239000000032 diagnostic agent Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011013 endotoxin removal Methods 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- KMNONFBDPKFXOA-UHFFFAOYSA-N prop-2-enamide;styrene Chemical compound NC(=O)C=C.C=CC1=CC=CC=C1 KMNONFBDPKFXOA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、蛋白質、核酸等の生体成分の分離精製に使用
されるクロマトグラフィーの吸着材、ドラッグ・デリバ
リ−・システム用担持体、免疫診断用ラテックスなどに
有用なキチン質又はキトサンを表面に修飾させた高分子
微粒子並びにその製造方法に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention is applicable to chromatography adsorbents used for the separation and purification of biological components such as proteins and nucleic acids, carriers for drug delivery systems, and immunodiagnosis. The present invention relates to polymer particles whose surfaces are modified with chitin or chitosan, which are useful for latex, etc., and a method for producing the same.
従来、抗原抗体反応を利用した免疫学的臨床検査診断薬
に疎水性表面を有するポリスチレンラテックスが用いら
れている(JColloid LnterfaceSc
i、、 71.350 (1979)。Conventionally, polystyrene latex with a hydrophobic surface has been used for diagnostic reagents for immunological clinical tests that utilize antigen-antibody reactions (JColloid LnterfaceSc
i, 71.350 (1979).
しかし、ポリスチレンラテックスは疎水性であるため、
感作安定性、保存安定性が欠けるため、疎水性を改質す
るためスチレンにメタクリル酸等を共重合させた微粒子
高分子の研究、開発も行われている。However, since polystyrene latex is hydrophobic,
Because of the lack of sensitization stability and storage stability, research and development are also being conducted on particulate polymers made by copolymerizing styrene with methacrylic acid, etc., in order to modify the hydrophobicity.
上記スチレンラテックスにおいては、感作安定性、保存
安定性に欠け、またメタクリル酸等を共重合させたスチ
レン系ラテックスでもその感作安定性、保存安定性が十
分でないばかりでなく、これらスチレン系ラテックスに
おいては非特異的な凝集反応を有し、抗原或は抗体を固
定化した免疫学的血清、血漿、尿等の高感度、定量分析
用ラテックスとしては満足するものではない。The above-mentioned styrene latex lacks sensitization stability and storage stability, and even styrene latex copolymerized with methacrylic acid etc. not only has insufficient sensitization stability and storage stability; It has a non-specific agglutination reaction and is not satisfactory as a latex for highly sensitive and quantitative analysis of immunological serum, plasma, urine, etc. on which antigens or antibodies are immobilized.
本発明はラテックスを親水性に改良し、更に好適には正
荷電性へ変換させて動物細胞、免疫蛋白質等の生体高分
子に対する親和性を向上させ蛋白質、核酸等の生体成分
に特異的な吸着性を有し、ドラッグ・デリバリ−・シス
テム用担持体、免疫診断用ラテックス等として有用な高
分子微粒子並びにその製造方法を提供することを目的と
するものである。The present invention improves latex to be hydrophilic, and more preferably converts it to positively charged property to improve its affinity for biopolymers such as animal cells and immune proteins, and to specifically adsorb latex to biocomponents such as proteins and nucleic acids. The object of the present invention is to provide polymeric microparticles that have properties and are useful as carriers for drug delivery systems, latex for immunodiagnosis, etc., and a method for producing the same.
本発明等はバイオアフィニティー成分、生理活性物質、
薬剤などの固定、免疫学的臨床検査診断薬、エンドトキ
シン除去剤として使用される高分子微粒子を開発する目
的で蛋白質、酵素等の生体高分子に対して選択的な吸着
性及び親和性を有するキチンの構成単位であるグルコサ
ミンを有し、しかも好ましくは正荷電をも有するキチン
誘導体並びにキトサンを高分子微粒子の表面に修飾させ
てドラッグ・デリバリ−・システム用担持体、免疫診断
薬用ラテックス等に極めて使用し易い高分子微粒子形態
で提供し得ること並びにそのキチン誘導体、キトサンの
高分子物への修飾方法を見出し本発明を完成した。The present invention etc. are bioaffinity components, physiologically active substances,
Chitin, which has selective adsorption and affinity for biopolymers such as proteins and enzymes, is used for the purpose of developing polymeric microparticles used as immobilization of drugs, diagnostic agents for immunological clinical tests, and endotoxin removal agents. Chitin derivatives and chitosan, which have glucosamine as a constituent unit and preferably also have a positive charge, can be modified on the surface of polymeric particles and used as carriers for drug delivery systems, latex for immunodiagnostic agents, etc. The present invention was completed by discovering that chitin derivatives and chitosan can be easily provided in the form of fine polymer particles, and a method for modifying chitin derivatives and chitosan into polymers.
本発明は、キチン誘導体又はキトサンを表面に修飾した
高分子微粒子である。そしてカルボキシルラテックス微
粒子を式
RN=C=NR’ (式中Rはエチル基、R′はジメチ
ルアミノプロピル基又はR,R’は共にシクロヘキシル
基を示す)で表わされるカルボジイミド化合物と反応さ
せ、次いでキチン誘導体又はキトサンを反応させること
を特徴とするキチン誘導体又はキトサンを表面に修飾し
た高分子微粒子の製造方法である。The present invention is a polymer fine particle whose surface is modified with a chitin derivative or chitosan. Then, the carboxyl latex fine particles are reacted with a carbodiimide compound represented by the formula RN=C=NR' (wherein R is an ethyl group, R' is a dimethylaminopropyl group, or both R and R' are a cyclohexyl group), and then chitin This is a method for producing polymer fine particles whose surface is modified with a chitin derivative or chitosan, which is characterized by reacting the derivative or chitosan.
本発明に使用する高分子微粒子はカルボジイミド化合物
と反応する活性基を有する高分子化合物であり、カルボ
キシルラテックスが好適である。そしてその粒径は製品
の用途により適宜選択されるが、大体0.2〜10μm
が普通使用される。The polymer fine particles used in the present invention are polymer compounds having an active group that reacts with a carbodiimide compound, and carboxyl latex is preferable. The particle size is selected appropriately depending on the application of the product, but it is approximately 0.2 to 10 μm.
is commonly used.
この高分子微粒子に修飾されるキチン誘導体としては、
水溶性のキチン誘導体、例えば、ジエチルアミノエチル
キチン、カルボキシメチルキチン、ヒドロキシプロピル
キチン、ヒドロキシエチルキチン、硫酸エステルキチン
、リン酸エステルキチン等が好適に用いられ、本発明者
等が先に発表したジエチルアミノエチルキチン[Pol
ymer Bulletin、 21.13−17(1
989) Eが最も適している。キトサンもキチンを脱
アセチル化したものでキチンの構成単位であるグルコサ
ミンを有し、しかも正電荷を有する物質であり、本発明
に好適に適用できる。The chitin derivatives modified into these polymer particles include:
Water-soluble chitin derivatives such as diethylaminoethyl chitin, carboxymethyl chitin, hydroxypropyl chitin, hydroxyethyl chitin, sulfate ester chitin, phosphate ester chitin, etc. are preferably used, and the diethylaminoethyl chitin previously announced by the present inventors Chitin [Pol
ymer Bulletin, 21.13-17 (1
989) E is the most suitable. Chitosan is also a substance obtained by deacetylating chitin, contains glucosamine, which is a constituent unit of chitin, and is a positively charged substance, and can be suitably applied to the present invention.
以上のように、本発明の高分子微粒子は表面にキチン誘
導体又はキトサンを修飾したものであるから、表面が正
電荷性及び親水性を有する微粒子と改質され、微粒子で
あるため表面積が犬で、しかも表面の電荷密度が高くそ
の表面活性を利用して各種の蛋白質、酵素などの生体高
分子の吸着、脱着及び抗原又は抗体を固定化するイムノ
ミクロスファアによる診断剤として有用に使用できると
共に、医薬品の副作用原因の一つである発熱物質エンド
トキシンを選択的に吸着除去剤としての用途も期待され
る。また保水性を利用し整髪剤などの化粧品成分材料と
しても使用できる極めて有用なものである。As described above, the polymer particles of the present invention have surfaces modified with chitin derivatives or chitosan, so the surfaces are modified to have positively charged and hydrophilic properties, and because they are fine particles, the surface area is small. In addition, the surface charge density is high, and by utilizing the surface activity, it can be usefully used as a diagnostic agent by adsorbing and desorbing biopolymers such as various proteins and enzymes, and by immobilizing antigens or antibodies. It is also expected to be used as a selective adsorbent and remover for endotoxin, a pyrogenic substance that is one of the causes of side effects of pharmaceuticals. Moreover, it is extremely useful because it can be used as a cosmetic component material such as a hair styling agent due to its water-retaining properties.
上記キチン誘導体又はキトサンを有する高分子微粒子を
製造するには、カルボキシル基などの活性基を有する高
分子微粒子、好適にはカルボキシルラテックス、この物
質は例えば、スチレンモノマーを単独で重合させ核粒子
とした後、アクリルアミドを添加し、2段重合法により
精製したスチレン−アクリルアミド共重合ラテックスを
加水分解することにより得られる。In order to produce the above-mentioned polymer fine particles having a chitin derivative or chitosan, polymer fine particles having an active group such as a carboxyl group, preferably carboxyl latex, are used, and this material is made by polymerizing, for example, a styrene monomer alone and forming a core particle. Thereafter, acrylamide is added and the styrene-acrylamide copolymer latex purified by a two-stage polymerization method is hydrolyzed.
この高分子微粒子に水を媒体として水溶性の一般式RN
=C=NR’ (式中、R,R’は前記と同一意義を
有す。)で表わされるカルボジイミド化合物、1−エチ
ル−5−(3−ジメチルアミノプロピル)カルボジイミ
ド、1.3−ジシクロへキシルカルボジイミドを常温で
反応させ、次にチキン誘導体又はキトサンを加え約12
時間位常温で反応すると本発明のキチン誘導体又はキト
サンを表面に修飾した高分子微粒子が得られる。The water-soluble general formula RN
=C=NR' (wherein R, R' have the same meanings as above), a carbodiimide compound, 1-ethyl-5-(3-dimethylaminopropyl)carbodiimide, 1,3-dicyclo React xylcarbodiimide at room temperature, then add chicken derivative or chitosan for about 12 hours.
When the reaction is carried out at room temperature for about a period of time, polymer fine particles whose surfaces are modified with the chitin derivative or chitosan of the present invention are obtained.
本方法におけるキチン誘導体及びキトサンの使用量は高
分子のカルボキシル基に対し、キチン誘導体又はキトサ
ンのアミノ基として1〜8倍モル量が適当であり、4〜
8倍モル量が好適である。又、水溶性カルボジイミド化
合物の使用量は、キチン誘導体又はキトサンのアミノ基
に対し0.5〜1.5倍モル量が適当であり、好適には
0.8〜1.2倍モル量である。The appropriate amount of the chitin derivative and chitosan used in this method is 1 to 8 times the molar amount of the amino group of the chitin derivative or chitosan relative to the carboxyl group of the polymer, and 4 to 8 times the molar amount of the amino group of the chitin derivative or chitosan.
An 8-fold molar amount is preferred. Further, the amount of water-soluble carbodiimide compound to be used is suitably 0.5 to 1.5 times the molar amount, preferably 0.8 to 1.2 times the molar amount of the amino group of the chitin derivative or chitosan. .
次に本発明の微粒子の製造法並びに得られた物質の性質
を記載する。Next, the method for producing the fine particles of the present invention and the properties of the obtained materials will be described.
例 1
表面電荷量89.5μ当量/g・ラテックス、粒径0.
6μm、比表面積10rri/g・ラテックスのカルボ
キシルラテックスの分散液(濃度0.0157g/mf
f) 400dに1−エチル−3−(3−ジメチルアミ
ノプロピル)カルボジイミド塩酸塩0.0108gを加
え、室温で2時間撹拌する。次いで1%ジエチルアミノ
エチルキチン水溶液63g(ラテックス中のカルボキシ
ル基に対してジエチルアミノエチルキチンのアミン基と
して2倍モル量)を加え、12時間反応させ、次いで2
M酢酸緩衝液(PH= 4 )を加えて2時間撹拌し得
られた生成物を決別する。その復水で洗浄し、減圧乾燥
しジエチルアミノエチルキチン修飾ラテックス0.68
gを得た。このものの表面荷電量は24.6μ当量/
g・ラテックスであった。また、得られたラテックスの
接触角(θ)は26.4であった。なお表面荷電量はコ
ロイド滴定により測定し、接触角は自動式PHW型接触
角計で測定した。Example 1 Surface charge: 89.5μ equivalent/g latex, particle size: 0.
Carboxyl latex dispersion with a specific surface area of 10 rri/g/latex (concentration 0.0157 g/mf)
f) Add 0.0108 g of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride to 400 d and stir at room temperature for 2 hours. Next, 63 g of a 1% diethylaminoethyl chitin aqueous solution (twice the molar amount as the amine group of diethylaminoethyl chitin relative to the carboxyl group in the latex) was added, and the mixture was reacted for 12 hours.
Add M acetate buffer (PH=4), stir for 2 hours, and separate the resulting product. Washed with condensed water and dried under reduced pressure to obtain diethylaminoethyl chitin modified latex 0.68
I got g. The surface charge amount of this material is 24.6μ equivalent/
g. It was latex. Further, the contact angle (θ) of the obtained latex was 26.4. Note that the surface charge amount was measured by colloid titration, and the contact angle was measured using an automatic PHW type contact angle meter.
例2〜3
1−エチル−5−(3−ジメチルアミノプロピル)カル
ボジイミド塩酸塩(WSC)及び1%ジエチルアミノエ
チルキチン水溶液(DEAE−キチン水溶液)を第1表
に示す量加えた以外は例1と同様の操作を行い、DEA
E−キチン修飾ラテックスを得た。この例の収量、表面
荷電量及び接触角は第1表の通りであった。なお、1%
DEAE−キチン量はラテックス中のカルボキシル基に
対してDEAE−キチンのアミン基として4倍乃至8倍
モル量である。Examples 2-3 Same as Example 1 except that 1-ethyl-5-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSC) and 1% diethylaminoethyl chitin aqueous solution (DEAE-chitin aqueous solution) were added in the amounts shown in Table 1. Perform the same operation and DEA
E-chitin modified latex was obtained. The yield, surface charge amount, and contact angle of this example were as shown in Table 1. In addition, 1%
The amount of DEAE-chitin is 4 to 8 times the molar amount of the amine group of DEAE-chitin relative to the carboxyl group in the latex.
第
表
例4〜6
1%DEAE−キチン水溶液を1%キトサン水溶液に代
え、WSC及び1%キトサン水溶液量を第2表に示す量
を加えた以外は実施例1と同様の操作を行い、キトサン
修飾ラテックスを得た。この例の収量、表面荷電量及び
接触角は第2表の通りであった。なお、1%キトサン水
溶液量はラテックス中のカルボキシル基に対してキトサ
ンのアミノ基として2倍乃至8倍モル量である。Table Examples 4 to 6 The same operation as in Example 1 was performed except that the 1% DEAE-chitin aqueous solution was replaced with a 1% chitosan aqueous solution and the amounts of WSC and 1% chitosan aqueous solution shown in Table 2 were added. Obtained modified latex. The yield, surface charge amount, and contact angle of this example were as shown in Table 2. The amount of the 1% chitosan aqueous solution is 2 to 8 times the molar amount of the amino groups of chitosan relative to the carboxyl groups in the latex.
以下余白
第
表
例 7
表面荷電量38.5μ当量/g・ラテックス、濃度0.
0175 g /dのカルボキシルラテックス水分散液
40−を用い、WSC000052g、1%DEAE−
キチン水溶液3.Og (ラテックス中のカルボキシル
基に対してDEAE−キチンのアミノ基として2倍モル
量)加えた以外は、実施例1と同様の操作を行い、DE
AE−キチン修飾ラテックス0.81gを得た。このも
のの表面荷電量は21.6μ当量/g・ラテックスであ
った。Below is an example of the table in the margin 7 Surface charge amount 38.5μ equivalent/g latex, concentration 0.
Using carboxyl latex aqueous dispersion 40-0175 g/d, WSC000052 g, 1% DEAE-
Chitin aqueous solution 3. The same operation as in Example 1 was carried out except that Og (twice the molar amount as the amino group of DEAE-chitin relative to the carboxyl group in the latex) was added.
0.81 g of AE-chitin modified latex was obtained. The surface charge amount of this product was 21.6 μequivalent/g·latex.
例 8
1%DEAE−キチン水溶液を1%キトサン水溶液1.
1g (ラテックス中のカルボキシル基に対してキトサ
ンのアミノ基として2倍モル量)に代えた以外は、例7
と同様の操作を行い、キトサン修飾ラテックス0.97
gを得た。このものの表面荷電量は4.3μ当量/g・
ラテックスであった。Example 8 1% DEAE-chitin aqueous solution and 1% chitosan aqueous solution 1.
Example 7 except that 1 g (twice the molar amount of the amino group of chitosan relative to the carboxyl group in the latex)
Perform the same operation as above to obtain chitosan-modified latex 0.97
I got g. The surface charge amount of this material is 4.3μ equivalent/g・
It was latex.
本発明は微粒子上に親水性好ましくは更に正荷電をも有
するキチンの構成単体を持つ物質を修飾した微粒子であ
り、これにより生体高分子に対する特異の親和性を有す
るためバイオアフィニティー成分、生理活性物質、薬剤
などの固定、免疫診断薬用ラテックス、エンドトキシン
除去剤として極めて広範囲の用途を有する物質を提供す
る有用な発明である。The present invention is a microparticle modified with a substance having a hydrophilic, preferably positively charged constituent element of chitin on the microparticle, which has a specific affinity for biopolymers and is therefore a bioaffinity component and a physiologically active substance. This is a useful invention that provides a substance that has an extremely wide range of uses, such as fixation of drugs, latex for immunodiagnostics, and endotoxin removal agent.
Claims (1)
微粒子。 2、キチン誘導体がジエチルアミノエチルキチンである
請求項1記載の高分子微粒子。 3、高分子微粒子がカルボキシルラテックスである請求
項1記載の高分子微粒子。 4、カルボキシルラテックス微粒子に式RN=C=NR
′(式中Rはエチル基、R′はジメチルアミノプロピル
基又はR、R′は共にシクロヘキシル基を示す)を有す
るカルボジイミド化合物を反応させ、次いでキチン誘導
体又はキトサンを反応させることを特徴とするキチン誘
導体又はキトサンを表面に修飾した高分子微粒子の製造
方法。 5、キチン誘導体がジエチルアミノエチルキチンである
請求項4記載の高分子微粒子の製法。[Scope of Claims] 1. Polymer fine particles whose surface is modified with a chitin derivative or chitosan. 2. The polymer fine particles according to claim 1, wherein the chitin derivative is diethylaminoethyl chitin. 3. The polymeric fine particles according to claim 1, wherein the polymeric fine particles are carboxyl latex. 4. Carboxyl latex fine particles have the formula RN=C=NR
' (in the formula, R is an ethyl group, R' is a dimethylaminopropyl group, or both R and R' are a cyclohexyl group), and then a chitin derivative or chitosan is reacted. A method for producing polymer fine particles whose surfaces are modified with a derivative or chitosan. 5. The method for producing fine polymer particles according to claim 4, wherein the chitin derivative is diethylaminoethyl chitin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2122459A JPH0421637A (en) | 1990-05-11 | 1990-05-11 | High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2122459A JPH0421637A (en) | 1990-05-11 | 1990-05-11 | High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0421637A true JPH0421637A (en) | 1992-01-24 |
Family
ID=14836382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2122459A Pending JPH0421637A (en) | 1990-05-11 | 1990-05-11 | High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0421637A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07216256A (en) * | 1994-01-28 | 1995-08-15 | Suzuki Yushi Kogyo Kk | Colored fine particle and its production |
EP0747703A2 (en) * | 1995-06-09 | 1996-12-11 | Nisshinbo Industries, Inc. | Method for analyzing biological active substances |
WO2004014988A1 (en) * | 2002-08-09 | 2004-02-19 | Nisshinbo Industries, Inc. | Composite particle having carbodiimide resin layer and process for producing the same |
WO2006123686A1 (en) * | 2005-05-20 | 2006-11-23 | Jsr Corporation | Support polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same |
JP2006321932A (en) * | 2005-05-20 | 2006-11-30 | Jsr Corp | Carrier polymer particle and its production method |
JP2007145985A (en) * | 2005-11-28 | 2007-06-14 | Jsr Corp | Method for producing support polymer particle |
JP2008514424A (en) * | 2004-10-01 | 2008-05-08 | スリーエム イノベイティブ プロパティズ カンパニー | Composite filtration article |
US7387832B2 (en) | 2002-09-19 | 2008-06-17 | Nisshinbo Industries, Inc. | Flat particles and process for production thereof |
JP4272811B2 (en) * | 1997-09-05 | 2009-06-03 | マルホ株式会社 | Nanocapsule formulation for the treatment of intra-articular disease |
KR20180122188A (en) * | 2017-05-02 | 2018-11-12 | 포항공과대학교 산학협력단 | Nahochitin-nanochitosan complex body, network structure body comprising thereof and manufacturing methods thereof, respectively |
WO2020129404A1 (en) * | 2018-12-17 | 2020-06-25 | パナソニックIpマネジメント株式会社 | Modified particle, method for producing modified particle, and detection device |
-
1990
- 1990-05-11 JP JP2122459A patent/JPH0421637A/en active Pending
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07216256A (en) * | 1994-01-28 | 1995-08-15 | Suzuki Yushi Kogyo Kk | Colored fine particle and its production |
EP0747703A2 (en) * | 1995-06-09 | 1996-12-11 | Nisshinbo Industries, Inc. | Method for analyzing biological active substances |
EP0747703A3 (en) * | 1995-06-09 | 1998-09-09 | Nisshinbo Industries, Inc. | Method for analyzing biological active substances |
JP4272811B2 (en) * | 1997-09-05 | 2009-06-03 | マルホ株式会社 | Nanocapsule formulation for the treatment of intra-articular disease |
WO2004014988A1 (en) * | 2002-08-09 | 2004-02-19 | Nisshinbo Industries, Inc. | Composite particle having carbodiimide resin layer and process for producing the same |
US7258921B2 (en) | 2002-08-09 | 2007-08-21 | Nisshinbo Industries, Inc. | Composite particle with a carbodiimide resin layer and a process for producing the same |
US7387832B2 (en) | 2002-09-19 | 2008-06-17 | Nisshinbo Industries, Inc. | Flat particles and process for production thereof |
JP2008514424A (en) * | 2004-10-01 | 2008-05-08 | スリーエム イノベイティブ プロパティズ カンパニー | Composite filtration article |
WO2006123686A1 (en) * | 2005-05-20 | 2006-11-23 | Jsr Corporation | Support polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same |
JP2006321932A (en) * | 2005-05-20 | 2006-11-30 | Jsr Corp | Carrier polymer particle and its production method |
US9447232B2 (en) | 2005-05-20 | 2016-09-20 | Jsr Corporation | Carrier polymer particle, process for producing the same, magnetic particle for specific trapping, and process for producing the same |
JP2007145985A (en) * | 2005-11-28 | 2007-06-14 | Jsr Corp | Method for producing support polymer particle |
KR20180122188A (en) * | 2017-05-02 | 2018-11-12 | 포항공과대학교 산학협력단 | Nahochitin-nanochitosan complex body, network structure body comprising thereof and manufacturing methods thereof, respectively |
WO2020129404A1 (en) * | 2018-12-17 | 2020-06-25 | パナソニックIpマネジメント株式会社 | Modified particle, method for producing modified particle, and detection device |
CN112166315A (en) * | 2018-12-17 | 2021-01-01 | 松下知识产权经营株式会社 | Modified particle, method for producing modified particle, and detection device |
JPWO2020129404A1 (en) * | 2018-12-17 | 2021-11-04 | パナソニックIpマネジメント株式会社 | Modified particles, method for producing modified particles, and detection device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7582488B2 (en) | Gel-shell beads with adsorbed or bound biomolecules | |
JPS6315551B2 (en) | ||
JPH04339808A (en) | Bioactive reagent produced from carboxylated polymer, analytical element, and method for use | |
JPH03210476A (en) | Detection of antigen-antibody reaction and immobilization of antibody and enzyme | |
JPS5896616A (en) | Latex, biologically active latex conjugate and manufacture | |
JPS60142259A (en) | Immobilized antibody | |
JPH0421637A (en) | High polymer fine grain whose surface is modified with chitin derivative or chitosan and its production | |
US20090253220A1 (en) | Absorbing Biomolecules into Gel-Shell Beads | |
US6262256B1 (en) | Article for tuesyl-activated dextran for solid-phase coupling | |
US20050118199A1 (en) | Process for covalently conjugating polysaccharides to microspheres or biomolecules | |
Sarobe et al. | Functionalized monodisperse particles with chloromethyl groups for the covalent coupling of proteins | |
FI60319C (en) | FOERFARANDE FOER PAOVISNING ELLER BESTAEMNING AV ANTIKROPPAR I KROPPSVAETSKOR MED HJAELP AV KAENDA ANTIGENER ELLER FOER BESTTAEMNING AV ANTIGENER MED HJAELP AV KAENDA ANTIKROPPAR FRAON KROPPSVAETSKOR SAMT MED | |
EP0153763A2 (en) | Affinity chromatography matrix with built-in reaction indicator | |
NZ544585A (en) | Saquinavir mesylate oral dosage form | |
JPH073426B2 (en) | Carrier of diagnostic agglutination reagent | |
WO1984003358A1 (en) | Insoluble surfaces treated to inhibit non-specific protein binding | |
JPS635019A (en) | Microcapsuled ultrafine particle of magnetic substance carrying organism component | |
EP0569086A2 (en) | Method and kit for attaching compounds to carboxylated substrates using uronium salt | |
JPH0454905B2 (en) | ||
JPS61274261A (en) | Immunological diagnosis reagent | |
JPS6315553B2 (en) | ||
JPH0431669B2 (en) | ||
JPS62231169A (en) | Immunological diagnosing reagent | |
JPH0564741B2 (en) | ||
JPS6315552B2 (en) |